by jennieritchie | Company Update, News
A joint project for Perfectus Biomed Group, Magnitude Biosciences, and the University of Kent aims to provide an assay to aid research on infections caused by Pseudomonas aeruginosa, delivering a solution to accelerate wound care research and reduce the reliance on...
by jennieritchie | Company Update, News
Biofilm Awareness Week
Perfectus Biomed Group are excited to support The National Biofilms Innovation Centre (NBIC) #BiofilmWeek, highlighting the research taking place to prevent, detect, manage, and engineer biofilms. Perfectus Biomed’s mission is to harness...
by jennieritchie | Company Update, News
Perfectus Biomed Group have an actively innovative culture, and we strive to practice science that improves lives. Our unique specialism in biofilms, and our experience in customisable tissue models built the base for this particularly interesting study.
Biofilm forming...
by jennieritchie | Company Update, News
Do you always know what cell line you are working with? I am sure most of you reading this right now are nodding, confident in your cell line quality control, however there is a widely unknown reproducibility crisis that is threatening viral and mycobacterium contamination...
by jennieritchie | Company Update, News
Perfectus Biomed Group are leading the market with accredited biofilm test methods, and research & development. Our team in the US collaborated on a paper published in Communications Biology, that explored the antimicrobial potential of cannabidiol. The...
by jennieritchie | Company Update, News
Perfectus Biomed Group are excited to announce that we have recently received UKAS 17025 accreditation for the extension to scope for the Single Tube Method to include Candida albicans as a test organism. We are industry leaders in biofilm testing methods, please contact...
